Immunization for Adults Over 60: What Changes and Why

Why Immunity Shifts After 60

The immune system does not stay static across a lifetime. After roughly age 60, a process called immunosenescence — the gradual decline of immune function with age — alters both the speed and strength of the body's response to pathogens and vaccines alike. The practical consequence is that older adults face a higher risk of severe complications from infections that healthier, younger immune systems handle more readily.

Two components of immunity are particularly affected. First, the thymus, which produces T cells that coordinate immune responses, shrinks substantially by late adulthood, reducing the pool of naïve T cells available to recognize new threats. Second, the antibody responses generated after vaccination tend to be lower in magnitude and shorter in duration compared with those in younger adults. This is precisely why vaccine developers and regulators have created age-specific formulations and dosing strategies — not because vaccines work differently in principle, but because older immune systems need a stronger signal to mount adequate protection.

Understanding this biology matters because it explains why simply checking off childhood vaccines is not enough. Adults over 60 need vaccines that account for this changed immune landscape. You can learn more about how gaps in adult immunity develop in our article on immunity gaps adults often don't know they have.

Key Vaccines Recommended for Adults Over 60

Current ACIP and CDC guidance identifies several vaccines as priorities for adults in this age group. The following are among the most clinically significant.

Shingles (Recombinant Zoster Vaccine)

Shingles — caused by reactivation of the varicella-zoster virus that causes chickenpox — becomes markedly more common and more severe after age 50. The recombinant zoster vaccine (RZV, brand name Shingrix) is given as two doses and is recommended for all immunocompetent adults 50 and older, as well as certain immunocompromised adults 19 and older. It offers substantially higher and more durable protection than the older live-attenuated vaccine it replaced.

Pneumococcal Vaccines

Pneumococcal disease — which can cause pneumonia, meningitis, and bloodstream infections — carries higher mortality in older adults. Adults 65 and older who have not been vaccinated should receive either PCV20 alone, or PCV15 followed by PPSV23. Those with certain chronic conditions may need vaccination earlier or on a different schedule.

Influenza

Adults 65 and older should receive a high-dose or adjuvanted influenza vaccine each season. These formulations elicit a stronger immune response than standard-dose options, which is important given the blunted vaccine response associated with immunosenescence.

COVID-19

Older adults remain among the highest-risk groups for severe COVID-19. Updated vaccines are released periodically to match circulating variants, and ACIP recommendations evolve accordingly. Speak with your provider about the current-season recommendation.

Tdap and Td

Any adult who has never received a Tdap dose should do so, followed by Td or Tdap boosters every ten years. Pertussis protection from childhood vaccination wanes over decades and is not reliably lifelong.

How Underlying Conditions Change the Picture

Chronic conditions common in older adults — including diabetes, heart disease, chronic kidney disease, and conditions requiring immunosuppressive therapy — can further modify vaccine recommendations. In some cases, additional doses or earlier vaccination is warranted; in others, live-attenuated vaccines may be contraindicated.

For example, adults with functional or anatomic asplenia face heightened susceptibility to encapsulated bacteria and may require additional pneumococcal or meningococcal vaccination. Those receiving immunosuppressive medications, such as corticosteroids or biologic therapies, may need to avoid certain live vaccines entirely and may produce weaker responses to inactivated vaccines. Our article on why some people need additional or earlier doses covers these medical nuances in greater depth.

The key takeaway is that a one-size-fits-all approach does not apply. Vaccine needs in this age group are meaningfully individual, shaped by health history, current medications, and prior immunization records.

This article is for general health information only and does not constitute medical advice. Always consult a qualified healthcare provider before making decisions about vaccines or your personal health.

Talking to Your Provider and Staying on Track

One of the most practical steps any adult over 60 can take is to schedule a dedicated immunization review with their primary care provider or pharmacist. Bring whatever records you have, or ask for help retrieving them through state immunization registries or prior clinics. If your records are incomplete, our guide on getting your vaccination records in order offers step-by-step guidance for tracking them down.

During your review, ask specifically: Am I up to date on shingles, pneumococcal, flu, COVID-19, and Tdap vaccines? Do any of my health conditions change what I need? These direct questions help ensure nothing is missed.

Vaccine schedules for older adults are not static. ACIP updates its adult immunization schedule annually, and new products or reformulations periodically enter recommendations. Making immunization review a routine part of annual preventive care — rather than something addressed only when illness strikes — is the most reliable way to stay protected.